Counterfeit drugs: a global problem

Print 30 March 2016
Victoria White / European Pharmaceutical Review

In a recent issue of European Pharmaceutical Review, David Shore from Pfizer discussed his company’s progress in combatting the illegal trade of counterfeit drugs.

The trade in fake drugs is considerable; according to Pfizer’s own company records, more than 200 million counterfeit doses of Pfizer product alone have been intercepted since 2004. Indeed, the pharmaceutical industry takes counterfeiting very seriously. Last month, at PharmaPack Europe, the issue was chief among the event’s themes.

We’ve created an infographic on counterfeit drugs, highlighting some of the actions taken to counter this global problem:

Source

Return